SCHEMBL2404286

SCHEMBL2404286

O=C(C[S+](c1ccccc1)c1ccccc1)c1ccc(Cl)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.56
L3MBTL1 Q9Y468 2/20 0.56
GSK3B P49841 3/20 0.50
HSD11B1 P28845 2/20 0.50
CES2 O00748 1/20 0.50
CES1 P23141 1/20 0.50
ERCC5 P28715 1/20 0.49
FEN1 P39748 1/20 0.49
PABPC1 P11940 1/20 0.47
KMT2A Q03164 4/20 0.46
MEN1 O00255 3/20 0.46
HPGD P15428 1/20 0.46
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
ALOX15 P16050 1/20 0.45
TSHR P16473 1/20 0.45
ALDH1A1 P00352 2/20 0.43
NR4A1 P22736 1/20 0.43
PDPK1 O15530 1/20 0.43
TRPA1 O75762 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9003443 0.93 MAPT (0.51) MAPTL3MBTL1GSK3BHSD11B1CES2
SCHEMBL1095578 0.87 TDP1 (0.54) MAPTL3MBTL1GSK3BCES2CES1
SCHEMBL11700913 0.83 MAPT (0.53) MAPTL3MBTL1GSK3BHSD11B1CES2
SCHEMBL9003649 0.82 KMT2A (0.59) MAPTL3MBTL1GSK3BHSD11B1CES2
SCHEMBL9003605 0.82 L3MBTL1 (0.40) MAPTL3MBTL1GSK3BHSD11B1CES2
Perchlorate SCHEMBL9003671 0.80 TDP1 (0.47) MAPTL3MBTL1GSK3BCES2CES1
SCHEMBL8855000 0.80 MAPT (0.47) MAPTL3MBTL1GSK3BCES1ERCC5
SCHEMBL2330045 0.78 GSK3B (0.53) MAPTL3MBTL1GSK3BHSD11B1KMT2A
SCHEMBL1127785 0.78 HSD11B1 (0.39) MAPTL3MBTL1GSK3BHSD11B1CES2
Perchlorate SCHEMBL8752338 0.77 KMT2A (0.53) MAPTL3MBTL1GSK3BHSD11B1CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130299736-A1 RADIATION-CURABLE COATING MATERIALS BASE SE (DE) 2013-11-14 US disclosed
US-20110230617-A1 RADIATION-CURABLE COATING MATERIALS BASF SE (DE) 2011-09-22 US disclosed
US-20100126386-A1 RADIATION-CURABLE COATING SUBSTANCES BASF AKTIENGESELLSCHAFT (DE) 2010-05-27 US disclosed
US-6110987-A CURED PRODUCTS HAVING AN EXCELLENT APPEARANCE WITHOUT COLORING CAUSED BY POLYMERIZATION INITIATOR SHOWA DENKO K.K. (JP) 2000-08-29 US disclosed
US-5500453-A INITIATOR FOR PHOTOSENSITIVE FREE RADICAL CURING/ POLYMERIZATION OF UNSATURATED COMPOUNDS TOYO INK MANUFACTURING CO., LTD. (JP) 1996-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230617-A1 RADIATION-CURABLE COATING MATERIALS RAD51, MGMT, RAD54L MAPT 34/4885L3MBTL1 1658/4885GSK3B 1584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.